By

The U.S. Food and Drug Administration today approved Entresto (sacubitril/valsartan) tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and...

By

The U.S. Food and Drug Administration today approved the first drug for cystic fibrosis directed at treating the cause of the disease in people who have two copies of a specific mutation. Orkambi (lumacaftor...

The increase in microbial resistance to common antibiotics has led researchers to seek alternative means for treating infectious diseases.  A recent study in Nano Letters by a team from MIT and Harvard...

By

The U.S. Food and Drug Administration today announced its intention to take enforcement action against companies that manufacture and/or distribute certain unapproved prescription ear drop products (known...

By

The U.S. Food and Drug Administration today approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that...

By

The Honourable Rona Ambrose, Minister of Health, and Canada’s Chief Public Health Officer, Dr. Gregory Taylor, yesterday announced a $4.5 million USD contract between the Government of Canada and...

By

Governor Rick Scott has signed AB269—The Florida Right to Try Act—into law. The Right To Try Act allows doctors to prescribe treatments to the terminally ill that are being used in clinical trials...

By

The National Institutes of Health (NIH) Clinical Center has suspended operations of its Pharmaceutical Development Section (PDS) due to the discovery of serious manufacturing problems and lack of compliance...

By

Health Canada is warning consumers that an unauthorized drug, “Stiff Rock” promoted for male sexual performance enhancement was seized from Boutique Érotique 5ieme avenue (also known as Boutique Érotique...

By

The antibiotic meropenem was approved by the U. S. Food and Drug Administration for treating abdominal infections in children less than 3 months of age. The approval came after a study by a National Institutes...